Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2011
12/07/2011CN101574486B 治疗风寒感冒的中药胶囊剂的检测方法 Detection methods cure cold medicine capsules
12/07/2011CN101549016B 一种治疗急慢性咽炎的中药组合物及其制备方法 A treatment for acute and chronic pharyngitis Chinese medicine composition and its preparation method
12/07/2011CN101524388B 一种具有治疗鼻炎作用的药物组合物及其制备方法 A method of treating rhinitis effect of pharmaceutical compositions and its preparation method
12/07/2011CN101505737B 包含二氢吡啶类钙通道阻断剂和HMG-CoA还原酶抑制剂的控释组合药物制剂 Dihydropyridine calcium channel comprising a combination of controlled release pharmaceutical formulations blockers and HMG-CoA reductase inhibitor
12/07/2011CN101496870B 一种止咳化痰的中药组合物的检测方法 Detection of a cough and phlegm medicine composition
12/07/2011CN101492489B 银莲花素a的提取方法及其脂微球制剂的制备方法 Raddeanin a method of extracting and preparing method Lipo preparations
12/07/2011CN101474227B 白首乌提取物及其制备方法、应用、药物组合物 Baishouwu extract and its preparation method, application, pharmaceutical compositions
12/07/2011CN101434573B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method
12/07/2011CN101417014B 一种治疗淋症的中药组合物及其制备方法 A method of treating disease medicine cream composition and its preparation method
12/07/2011CN101396426B 一种甘草配方颗粒及其制备方法 One kind of particle licorice recipe and preparation method
12/07/2011CN101396343B 以脂质复合物为中间载体的紫杉醇亚微乳 Lipid complexes for intermediate vector paclitaxel submicroemulsion
12/07/2011CN101357117B 灯盏花素注射液及其制备方法 Breviscapine injection and its preparation method
12/07/2011CN101347535B 一种烧、烫、灼伤再生膏 One kind of burn, burn, burn cream regeneration
12/07/2011CN101342215B 一种木香动力胶囊 One kind of power woody capsules
12/07/2011CN101313990B 一种中药组合物在制备治疗神经官能症药物中的应用 Chinese medicinal composition for the manufacture of a medicament for the treatment of neurosis
12/07/2011CN101296688B 包含乙醇和不透x射线的脂溶性化合物的可注射粘稠医用制剂 Comprising ethanol and an x-ray impermeable lipophilic compound injectable viscous preparations for medical
12/07/2011CN101292965B 一种类β-胡萝卜素微囊及其制备方法 One kind of class β- carotene microcapsules and its preparation method
12/07/2011CN101278970B 东紫苏类黄酮的制备方法 Preparation East basil flavonoids
12/07/2011CN101243130B 显示具有改善的流动性的组合物 Display fluidity compositions having improved
12/07/2011CN101229258B 抗过敏消炎膏 Allergy-inflammatory cream
12/07/2011CN101199586B 一种用于紫癜的药物 A medicament for purpura
12/07/2011CN101177487B 温敏性可生物降解聚酸酐共聚物及其水凝胶体系和应用 Temperature-sensitive biodegradable polyanhydride copolymer hydrogels system and its application
12/07/2011CN101164578B 一种治疗痔疮的中药组合物及其制备方法 Chinese medicinal composition and preparation method for the treatment of hemorrhoids
12/07/2011CN101163479B 固体药物剂型 The solid pharmaceutical dosage form
12/07/2011CN101160116B 基于局部递送活性物质治疗前列腺疾病的方法 Local delivery of active substances to treat prostate disease-based approach
12/07/2011CN101134049B 一种增强免疫力和/或改善贫血的阿胶粉的制备方法 An immunity and preparation / or improve anemia A powder enhancements
12/07/2011CN101134026B 长春瑞滨软胶囊及其制备方法和其应用 Vinorelbine soft capsule and its preparation method and its application
12/07/2011CN101108245B 用于人肿瘤联合治疗的制剂及其用途 Combination therapy for human tumor preparation and use thereof
12/07/2011CN101102795B 用于抑制纤维化的药物载体和药物载体试剂盒 Drug carrier for inhibiting fibrosis and drug carrier kit
12/07/2011CN101088494B 肠溶包衣颗粒剂及其制备方法 Enteric-coated granules and its preparation method
12/07/2011CN101084904B 头孢克肟缓释双层片 Cefixime sustained release bilayer tablet
12/07/2011CN101040906B 一种治疗心脑血管疾病的注射剂及其制备方法和质控方法 An injection preparation method and quality control method of treating cardiovascular disease
12/07/2011CN101024015B 一种治疗阳痿、早泄、亚健康的黄羊杞参提取物 A treatment for impotence, premature ejaculation, sub Mongolian gazelle Qi Ginseng Extract
12/06/2011US8071756 Polysaccharide pseudo-sponge
12/06/2011US8071737 Nucleic acid ligand complexes
12/06/2011US8071619 Injectable liquid formulation of paracetamol
12/06/2011US8071582 Substituted aniline derivatives
12/06/2011US8071578 Tazarotene and corticosteroid treatment for psoriasis
12/06/2011US8071555 Protective skin care peptides
12/06/2011US8071537 Implantable device for the sustained release of a polypeptide
12/06/2011US8071309 Methods for rapid identification of pathogens in humans and animals
12/06/2011US8071134 treating subjects having conditions related to angiogenesis; thyroid hormone, thyroid hormone analog, or polymeric forms thereof
12/06/2011US8071133 Oral dosage forms of water insoluble drugs and methods of making the same
12/06/2011US8071132 Unagglomerated core/shell nanocomposite particles
12/06/2011US8071131 Mineralizing composite materials for restoring teeth
12/06/2011US8071130 Solid preparation
12/06/2011US8071129 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
12/06/2011US8071128 Growing a powder material including a sugar alcohol or a saccharide as a main ingredient into a granulated material with a fixed particle diameter, mixing granulated material with a drug and a disintegrant, then compressing into a shape
12/06/2011US8071127 Dual action, inhaled formulations providing both an immediate and sustained release profile
12/06/2011US8071124 Methods of using expandable foam-like biomaterials
12/06/2011US8071123 Process for producing edible orally administered agent of laminate film form and compression bonding apparatus
12/06/2011US8071121 Ophthalmically bioactive agent encapsulated in oil phase; capable of diffusion into and migration through contact lense and into post-lens tear film; stabilized by surfactant with sufficient packing at oil-water interface to attenuate rate of diffusion and migration; storage stability
12/06/2011US8071120 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides
12/06/2011US8071114 Compositions containing quaternary ammonium compounds
12/06/2011US8071082 Drug delivery of nucleic acids, Rna, Dna; polyamideester copolymer
12/06/2011US8071075 Physiologically active agent, octyl dimethyl-para-aminobenzoate, volatile liquid; applying a hormone by aerosol
12/06/2011US8071074 e.g. (6,7-(dimethoxyquinazolin-4-yl)-(3-ethynylphenyl)-amine; epidermal growth factor receptor (EGF-R) antagonist, tyrosine kinase inhibitor; hypersecretion of mucus in lungs: chronic bronchitis, acute asthma, cystic fibrosis, bronchiectasis, chronic obstructive lung disease
12/06/2011US8071073 Compositions comprising azelastine and methods of use thereof
12/06/2011US8070745 Medication infusion device using negatively biased ambient pressure medication chamber
12/06/2011DE202010017302U1 Retigabin-Tabletten, bevorzugt mit modifizierter Freisetzung Retigabine tablets, preferably modified release
12/06/2011CA2576135C Direct compression polymer tablet core
12/06/2011CA2569285C Methods of device-assisted drug delivery
12/06/2011CA2550100C Production and purification of esters of conjugated linoleic acids
12/06/2011CA2522291C Nasal pharmaceutical formulations and methods of using the same
12/06/2011CA2516863C Poloxamer emulsion preparations
12/06/2011CA2515146C Aerosol formulations and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem
12/06/2011CA2495341C Water-swellable polymers
12/06/2011CA2491317C Modafinil pharmaceutical compositions
12/06/2011CA2465248C Proteins stabilized with polysaccharide gums
12/06/2011CA2449520C Swallow tablet comprising paracetamol
12/06/2011CA2405031C Guaifenesin sustained release formulation and tablets
12/06/2011CA2328783C Human procalcitonin and the preparation and use thereof
12/06/2011CA2305683C Immunogenic peptides from the hpv e7 protein
12/06/2011CA2305665C A method for treating diabetes, hyperglycemia and hypoglycemia
12/03/2011CA2706272A1 Multi phase soft gel capsules, apparatus and method thereof
12/03/2011CA2706270A1 Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
12/01/2011WO2011150392A1 Delivery of therapeutic agents to inflamed tissues using folate-targeted agents
12/01/2011WO2011150306A1 Oral film dosage form having physical-chemical identifier thereon
12/01/2011WO2011150302A1 Oral film dosage form having indicia thereon
12/01/2011WO2011150264A2 Synthetic nanocarrier combination vaccines
12/01/2011WO2011150239A2 Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
12/01/2011WO2011150212A2 Magnetic nanoparticles
12/01/2011WO2011150181A2 Compositions and methods for treating or inhibiting infection by francisella tularensis
12/01/2011WO2011150175A2 Compositions and methods for pain reduction
12/01/2011WO2011150144A2 Aqueous formulations for coating microneedle arrays
12/01/2011WO2011150127A2 Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells
12/01/2011WO2011150102A1 Cyclosporin emulsions
12/01/2011WO2011149981A2 Oral formulations for counteracting effects of aging
12/01/2011WO2011149844A1 Delivery of high dose therapeutic radioisotopes to bone
12/01/2011WO2011149814A2 Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition
12/01/2011WO2011149689A1 Composition comprising biodegradable polymers for use in a cosmetic composition
12/01/2011WO2011149645A1 Topical etoricoxib formulation
12/01/2011WO2011149472A1 Method for preparing an enriched igg composition from plasma
12/01/2011WO2011149416A1 Aqueous dispersion comprising galactolipids and method for production thereof
12/01/2011WO2011149412A1 Injectable emulsion of sedative hypnotic agent
12/01/2011WO2011149349A1 2-iminobiotin formulations and uses thereof
12/01/2011WO2011149288A2 Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases, and pharmaceutical composition containing same
12/01/2011WO2011149206A2 Pharmaceutical composition containing crystalline nebivolol hydrochloride and method for preparing the same
12/01/2011WO2011149061A1 Composite body containing inactivated virus particle and use thereof
12/01/2011WO2011149016A1 Complex containing thrombolytic enzyme